If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

Novo Nordisk has announced an investment of 8.5 billion Danish kroner, or approximately $1.2bn, to establish a new rare ...

Gilead Sciences’ seladelpar has been recommended by the European Medicines Agency’s human medicines committee to treat the ...

Presenting your brand strategy for review by your most senior colleagues is a big deal, both professionally and personally.

Technology’s ability to accelerate the pace of innovation while reducing the cost is changing the dynamic of the struggle ...

As the awe of AI continues to dissipate, organisations are increasingly seeing this technology for its untapped promise to ...

Since the Orphan Drug Act was passed in 1983, pharmaceutical companies have increasingly focused on developing treatments for ...

My Texan friends call this ‘big hats, no cattle’, when senior management get a lot of what they like to see but little of ...

Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical ...

Amgen’s Blincyto (blinatumomab) has been granted a licence extension by the Medicines and Healthcare products Regulatory ...